DRC & Research News

This page shares the latest news in T1D research and DRC’s community.

Get the most recent diabetes research news, delivered straight to your inbox

Pancreatic islet

Islet Cell Transplantation After Pancreas Removal May Help Preserve Normal Blood Sugar

Pancreatic isletSurgery to remove all or part of the pancreas and then transplant a patient’s own insulin-producing islet cells appears to be a safe and effective final measure to alleviate pain from severe chronic pancreatitis and to help prevent surgically induced diabetes, according to a report published online by JAMA Surgery.

Chronic pancreatitis (CP) is an inflammatory disease that over time leads to loss of function of the pancreas and manifests with intractable pain, malabsorption and diabetes. While medical management and pain control are the initial approaches to CP, some patients need to undergo more invasive procedures to relieve ductal pressure in the pancreas. If those measures fail, surgical options can include total removal of the pancreas (total pancreatectomy, TP) or the Whipple procedure to remove part of the pancreas. Total pancreas removal produces diabetes because insulin-secreting cells are removed. Autologous islet transplantation (AIT) was first described in the 1970s as a potential way to preserve normal blood glucose levels after near-total or total pancreas removal. However, few medical centers worldwide offer such treatment for patients with CP, according to background information in the study.Denise S. Tai, M.D., of the University of California, Los Angeles, and co-authors examined the outcomes of nine patients (5 male) who underwent pancreatic resection and AIT at the UCLA Center for Pancreatic Diseases between March 2007 and December 2013. It was a two-center collaboration with the University of California, San Francisco, handling isolation of the islet cells from the pancreatic tissue after removal.

Results show that eight of nine patients had successful procedures to isolate islet cells after their total or partial pancreas removal. Two of the patients did not require insulin and one required a low dose. All nine patients had less pain or were pain free two months after surgery.

“Pancreatic resection with AIT for severe CP is a safe and effective final alternative to ameliorate debilitating pain and to help prevent the development of surgical diabetes. It is practiced at only a few specialized centers worldwide because of the need for multidisciplinary coordination and care of these patients. … However, with the practice of geographically remote islet isolation by means of institutional collaboration, many more patients with CP may have access to and may greatly benefit from this procedure,” the authors conclude.


Story Source:

The above story is based on materials provided by The JAMA Network Journals.Note: Materials may be edited for content and length.


Journal Reference:

  1. Denise S. Tai, Na Shen, Gregory L. Szot, Andrew Posselt, Nicholas J. Feduska, Andrew Habashy, Barbara Clerkin, Erin Core, Ronald W. Busuttil, O. Joe Hines, Howard A. Reber, Gerald S. Lipshutz. Autologous Islet Transplantation With Remote Islet Isolation After Pancreas Resection for Chronic Pancreatitis.JAMA Surgery, 2014; DOI: 10.1001/jamasurg.2014.932

Cite This Page:

The JAMA Network Journals. “Islet cell transplantation after pancreas removal may help preserve normal blood sugar.” ScienceDaily. ScienceDaily, 10 December 2014. <www.sciencedaily.com/releases/2014/12/141210162322.htm>.

 

 

Learn More +

OUR PROJECTS

See our approved research projects and campaigns.

Role of the integrated stress response in type 1 diabetes pathogenesis
In individuals with type 1 diabetes (T1D), the insulin-producing beta cells are spontaneously destroyed by their own immune system. The trigger that provokes the immune system to destroy the beta cells is unknown. However, accumulating evidence suggest that signals are perhaps first sent out by the stressed beta cells that eventually attracts the immune cells. Stressed cells adapt different stress mitigation systems as an adaptive response. However, when these adaptive responses go awry, it results in cell death. One of the stress response mechanisms, namely the integrated stress response (ISR) is activated under a variety of stressful stimuli to promote cell survival. However, when ISR is chronically activated, it can be damaging to the cells and can lead to cell death. The role of the ISR in the context of T1D is unknown. Therefore, in this DRC funded study, we propose to study the ISR in the beta cells to determine its role in propagating T1D.
Wearable Skin Fluorescence Imaging Patch for the Detection of Blood Glucose Level on an Engineered Skin Platform
zhang
A Potential Second Cure for T1D by Re-Educating the Patient’s Immune System
L Ferreira
Validating the Hypothesis to Cure T1D by Eliminating the Rejection of Cells From Another Person by Farming Beta Cells From a Patient’s Own Stem Cells
Han Zhu
Taming a Particularly Lethal Category of Cells May Reduce/Eliminate the Onset of T1D
JRDwyer 2022 Lab 1
Can the Inhibition of One Specific Body Gene Prevent Type 1 Diabetes?
Melanie
Is Cholesterol Exacerbating T1D by Reducing the Functionality and Regeneration Ability of Residual Beta Cells?
Regeneration Ability of Residual Beta Cells
A Call to Question… Is T1D Caused by Dysfunctionality of Two Pancreatic Cells (β and α)?
Xin Tong
Novel therapy initiative with potential path to preventing T1D by targeting TWO components of T1D development (autoimmune response and beta-cell survival)
flavia pecanha